Cargando…
HPR108 Impact of COVID-19 Pandemic on the Decision Process of the Italian Medicine Agency: A Quantitative Assessment
Autores principales: | Fiorentino, F, Canali, B, Candelora, L, Halmos, T, La Malfa, P, Massara, F, Vassallo, C, Urbinati, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747501/ http://dx.doi.org/10.1016/j.jval.2022.09.1238 |
Ejemplares similares
-
COVID-19 impact on the decision process of the Italian Medicine Agency: a quantitative assessment
por: Canali, Beatrice, et al.
Publicado: (2023) -
Pharmacovigilance and the Italian Medicines Agency
por: Pimpinella, Giuseppe, et al.
Publicado: (2013) -
Infectious salmon anaemia virus (ISAV) in Chilean Atlantic salmon (Salmo salar) aquaculture: emergence of low pathogenic ISAV-HPR0 and re-emergence of virulent ISAV-HPR∆: HPR3 and HPR14
por: Godoy, Marcos G, et al.
Publicado: (2013) -
Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2021) -
Intellectual disability: an Italian perspective
por: La Malfa, Giampaolo, et al.
Publicado: (2007)